AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35590399 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum masking level (MML) audiological measurement
Number of subjects: 0
Study 33438255 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual education intervention
Number of subjects: 0
Study 33438255 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35442180 — intervention group
Group type: EXPERIMENTAL
Intervention: Good CPAP adherence (≥4 hours/night)
Number of subjects: 1803
Study 35442180 — intervention group
Group type: COMPARATOR
Intervention: Non-OSA group
Number of subjects: 1803
Study 34625591 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental implant design
Number of subjects: 20
Study 34625591 — intervention group
Group type: COMPARATOR
Intervention: Control implant design
Number of subjects: 20
Study 32469920 — intervention group
Group type: EXPERIMENTAL
Intervention: Timely, formative feedback and group feedback sessions
Number of subjects: 3
Study 35641443 — intervention group
Group type: EXPERIMENTAL
Intervention: guided eCBT‐I
Number of subjects: 52
Study 35641443 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 52
Study 33486637 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' prognostic awareness (PA)
Number of subjects: 16
Study 33486637 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' prognostic awareness (PA)
Number of subjects: 16
Study 33486637 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians' prognostic awareness (PA)
Number of subjects: 16
Study 33486637 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) correlation
Number of subjects: 16
Study 34843069 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord-derived mesenchymal stem cell (UC-MSC) treatment, administered as three infusions at 4-week intervals plus conventional treatment.
Number of subjects: 219
Study 34843069 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving conventional treatment only.
Number of subjects: 219
Study 34843069 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC treatment.
Number of subjects: 219
Study 36522208 — intervention group
Group type: EXPERIMENTAL
Intervention: Delamanid, linezolid, levofloxacin, and pyrazinamide for 9 months
Number of subjects: 214
Study 36522208 — intervention group
Group type: COMPARATOR
Intervention: Conventional 20–24 month regimen
Number of subjects: 214
Study 33595717 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation recording
Number of subjects: 133
Study 33595717 — intervention group
Group type: COMPARATOR
Intervention: No consultation recording (Control)
Number of subjects: 133
Study 33744350 — intervention group
Group type: EXPERIMENTAL
Intervention: BF-200 ALA
Number of subjects: 50
Study 33744350 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 50
Study 35811347 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine plus fesoterodine (80-4 mg)
Number of subjects: 12
Study 33713484 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection
Number of subjects: 17
Study 33713484 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injection
Number of subjects: 17
Study 35215544 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet (VegD)
Number of subjects: 20
Study 35215544 — intervention group
Group type: COMPARATOR
Intervention: Traditional mixed diet (MixD)
Number of subjects: 20
Study 34127041 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pre-visit preparation (PVP) + usual care
Number of subjects: 0
Study 34127041 — intervention group
Group type: EXPERIMENTAL
Intervention: Exome sequencing (ES) + usual care
Number of subjects: 0
Study 34127041 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP + ES + usual care
Number of subjects: 0
Study 34127041 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 36034207 — intervention group
Group type: EXPERIMENTAL
Intervention: Entresto 50 mg + basic treatment
Number of subjects: 78
Study 36034207 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment
Number of subjects: 78
Study 34164855 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day of crocin
Number of subjects: 72
Study 34164855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 33267734 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed suture
Number of subjects: 184
Study 33267734 — intervention group
Group type: COMPARATOR
Intervention: Conventional interrupted sutures
Number of subjects: 184
Study 33267734 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 184
Study 34706980 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency airway oscillation (HFAO) device (Aerosure)
Number of subjects: 104
Study 34706980 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 104
Study 33920012 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide prevention public service announcements (PSAs) - 'Talk to someone', 'Find what works for you', 'Life can get better'
Number of subjects: 15
Study 33920012 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide prevention public service announcements (PSAs)
Number of subjects: 15
Study 35329218 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive-video games, 60 min group-based training program once per week for 12 weeks
Number of subjects: 16
Study 35329218 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 16
Study 33620272 — intervention group
Group type: EXPERIMENTAL
Intervention: <4 years
Number of subjects: 78
Study 33620272 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-7 years
Number of subjects: 78
Study 33620272 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-18 years
Number of subjects: 78
Study 32508221 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR; 6 mmol nitrate)
Number of subjects: 16
Study 32508221 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA; 0.0034 mmol nitrate)
Number of subjects: 16
Study 32508221 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR)
Number of subjects: 16
Study 32508221 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA)
Number of subjects: 16
Study 32508221 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR; 11.8 ± 2.5 mM)
Number of subjects: 16
Study 32508221 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA; 12.2 ± 2.3 mM)
Number of subjects: 16
Study 36228807 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (AL = 0‰)
Number of subjects: 352
Study 36228807 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (AL = 0-0.5‰)
Number of subjects: 352
Study 36228807 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (AL ≥ 0.5‰)
Number of subjects: 352
Study 36228807 — intervention group
Group type: COMPARATOR
Intervention: Control (AL = 0‰)
Number of subjects: 352
Study 32925494 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting interrupted by 3-min bouts of simple resistance activities (SRA) every 30 min
Number of subjects: 13
Study 32925494 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (SIT)
Number of subjects: 13
Study 35534868 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) environment for relaxation
Number of subjects: 100
Study 35534868 — intervention group
Group type: COMPARATOR
Intervention: Active control group applying a freely chosen relaxation method
Number of subjects: 100
Study 32820431 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic lozenges administered twice daily for 5 days (subgroup AI)
Number of subjects: 120
Study 32820431 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic lozenges administered twice daily for 5 days (subgroup BI)
Number of subjects: 120
Study 32820431 — intervention group
Group type: COMPARATOR
Intervention: Control subgroup AII
Number of subjects: 120
Study 32820431 — intervention group
Group type: COMPARATOR
Intervention: Control subgroup BII
Number of subjects: 120
Study 32820431 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup BI
Number of subjects: 120
Study 33501741 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline treatment (antibiotic group)
Number of subjects: 222
Study 33501741 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics (non-antibiotic group)
Number of subjects: 222
Study 32982191 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly professional cleaning and individual oral hygiene instructions by registered dental hygienists (RDHs)
Number of subjects: 146
Study 32982191 — intervention group
Group type: COMPARATOR
Intervention: Daily oral care as usual (self‐performed or nursing staff‐assisted)
Number of subjects: 146
Study 35948377 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS for 3 weeks
Number of subjects: 34
Study 35948377 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS for 3 weeks
Number of subjects: 34
Study 33486762 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical Hodgkin lymphoma (cHL) treatment
Number of subjects: 11841
Study 33486762 — intervention group
Group type: EXPERIMENTAL
Intervention: NHL diagnosis
Number of subjects: 11841
Study 33486762 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-free survival after NHL diagnosis
Number of subjects: 11841
Study 33486762 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival after NHL diagnosis
Number of subjects: 11841
Study 35436970 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct adjustment
Number of subjects: 0
Study 35436970 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverse-probability-of-treatment weighting (IPTW)
Number of subjects: 0
Study 35436970 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardisation
Number of subjects: 0
Study 35436970 — intervention group
Group type: EXPERIMENTAL
Intervention: Missing outcome data handling
Number of subjects: 0
Study 35436970 — intervention group
Group type: EXPERIMENTAL
Intervention: GetTested trial
Number of subjects: 0
Study 35101325 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 0
Study 35101325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33909857 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training over 16 weeks
Number of subjects: 21
Study 33909857 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) following their own daily activities
Number of subjects: 21
Study 36260627 — intervention group
Group type: EXPERIMENTAL
Intervention: favipiravir+placebo
Number of subjects: 240
Study 36260627 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir+placebo
Number of subjects: 240
Study 36260627 — intervention group
Group type: COMPARATOR
Intervention: placebo only
Number of subjects: 240
Study 36260627 — intervention group
Group type: EXPERIMENTAL
Intervention: favipiravir+lopinavir-ritonavir
Number of subjects: 240
Study 36260627 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir
Number of subjects: 240
Study 33280968 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education and decision aid tool about prescription pain relievers (N = 65)
Number of subjects: 124
Study 33280968 — intervention group
Group type: COMPARATOR
Intervention: Time-matched control (N = 59)
Number of subjects: 124
Study 33280968 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education and decision aid tool
Number of subjects: 124
Study 33620550 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (200 mg/day)
Number of subjects: 88
Study 33620550 — intervention group
Group type: COMPARATOR
Intervention: Placebo (rice flour)
Number of subjects: 88
Study 32701931 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic TMD group
Number of subjects: 30
Study 32701931 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic group
Number of subjects: 30
Study 36085061 — intervention group
Group type: EXPERIMENTAL
Intervention: OAD with antihypertensive drugs (test group)
Number of subjects: 180
Study 36085061 — intervention group
Group type: COMPARATOR
Intervention: OAD without hypertension (control group)
Number of subjects: 180
Study 34606574 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical racemic epinephrine pellets
Number of subjects: 13
Study 34606574 — intervention group
Group type: COMPARATOR
Intervention: Saline pellets
Number of subjects: 13
Study 32807173 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF)
Number of subjects: 70
Study 32807173 — intervention group
Group type: COMPARATOR
Intervention: Non-concentrated growth factors (Control)
Number of subjects: 70
Study 34352600 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aquatic aerobic exercise with usual antenatal care
Number of subjects: 320
Study 34352600 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal care alone
Number of subjects: 320
Study 32022954 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic midurethral sling procedures
Number of subjects: 0
Study 32022954 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical investigations and surgical treatments
Number of subjects: 0
Study 32022954 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized-controlled trials
Number of subjects: 0
Study 34115959 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-Loop Control (CLC)
Number of subjects: 168
Study 34115959 — intervention group
Group type: COMPARATOR
Intervention: Sensor-Augmented Pump (SAP)
Number of subjects: 168
Study 34896609 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal oxygen-ozone
Number of subjects: 49
Study 34896609 — intervention group
Group type: COMPARATOR
Intervention: Microdiscectomy
Number of subjects: 49
Study 34547486 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (0.25 mL rabies vaccine at day 0, 7 with IIV4)
Number of subjects: 100
Study 34547486 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (0.25 mL rabies vaccine at day 0, 28 with IIV4)
Number of subjects: 100
Study 34547486 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (0.25 mL rabies vaccine at day 0, 7)
Number of subjects: 100
Study 35655733 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-designed comprehensive pelvic floor training
Number of subjects: 88
Study 35655733 — intervention group
Group type: COMPARATOR
Intervention: Kegel motion (control group)
Number of subjects: 88
Study 32648175 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely Minimally Invasive Esophagectomy (CMIE)
Number of subjects: 147
Study 32648175 — intervention group
Group type: COMPARATOR
Intervention: Hybrid Esophagectomy (HE)
Number of subjects: 147
Study 33067294 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recruitment strategy (personal invitation by memory clinic team)
Number of subjects: 378
Study 33067294 — intervention group
Group type: COMPARATOR
Intervention: Passive recruitment strategy (poster and flyer in waiting room)
Number of subjects: 378
Study 33067294 — intervention group
Group type: EXPERIMENTAL
Intervention: Online tailor-made lifestyle advice regarding protective and risk factors for dementia
Number of subjects: 378
Study 35984998 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment (GA) intervention with summary and management recommendations provided to oncologists.
Number of subjects: 541
Study 35984998 — intervention group
Group type: COMPARATOR
Intervention: Usual care without GA summary provided to oncologists.
Number of subjects: 541
Study 32858111 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 238
Study 32858111 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Use
Number of subjects: 238
Study 32858111 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonwhite Race
Number of subjects: 238
Study 32858111 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodal Involvement
Number of subjects: 238
Study 32858111 — intervention group
Group type: EXPERIMENTAL
Intervention: CA19-9 ≥90 U/mL
Number of subjects: 238
Study 32891291 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage and patient education
Number of subjects: 130
Study 32891291 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 33863454 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered cryo-cabin
Number of subjects: 18
Study 33863454 — intervention group
Group type: COMPARATOR
Intervention: Open cryo-cabin
Number of subjects: 18
Study 35876447 — intervention group
Group type: EXPERIMENTAL
Intervention: Art therapy intervention
Number of subjects: 0
Study 35876447 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34661774 — intervention group
Group type: EXPERIMENTAL
Intervention: Graftless sinus augmentation
Number of subjects: 10
Study 34661774 — intervention group
Group type: COMPARATOR
Intervention: Conventional sinus augmentation (autografts and xenografts)
Number of subjects: 10
Study 34661774 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic rehabilitation
Number of subjects: 10
Study 32381162 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial septal aneurysm (ASA) with large PFO
Number of subjects: 898
Study 32381162 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial septal aneurysm (ASA) with nonlarge PFO
Number of subjects: 898
Study 32381162 — intervention group
Group type: EXPERIMENTAL
Intervention: Large PFO without ASA
Number of subjects: 898
Study 32381162 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlarge PFO without ASA
Number of subjects: 898
Study 32381162 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (antithrombotic therapy)
Number of subjects: 898
Study 35894448 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG-fluorescent imaging
Number of subjects: 102
Study 35894448 — intervention group
Group type: COMPARATOR
Intervention: 99m Tc-nanocoilloid
Number of subjects: 102
Study 35894448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ICG and 99m Tc-nanocoilloid
Number of subjects: 102
Study 35894448 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG-fluorescent imaging and 99m Tc-nanocoilloid
Number of subjects: 102
Study 33449509 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 148
Study 33449509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 32846768 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise combined with standardized drug therapy
Number of subjects: 64
Study 32846768 — intervention group
Group type: COMPARATOR
Intervention: Routine exercise combined with standardized drug therapy
Number of subjects: 64
Study 36084280 — intervention group
Group type: EXPERIMENTAL
Intervention: Community group interventions
Number of subjects: 5927
Study 36084280 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility interventions package
Number of subjects: 5927
Study 36084280 — intervention group
Group type: EXPERIMENTAL
Intervention: Community group intervention
Number of subjects: 5927
Study 36084280 — intervention group
Group type: COMPARATOR
Intervention: Community group and facility intervention
Number of subjects: 5927
Study 36084280 — intervention group
Group type: COMPARATOR
Intervention: Community group and facility interventions
Number of subjects: 5927
Study 35977716 — intervention group
Group type: EXPERIMENTAL
Intervention: Head constrained using a head, neck, and chest brace which restricted neck movement
Number of subjects: 12
Study 35977716 — intervention group
Group type: COMPARATOR
Intervention: No head constraint (control condition)
Number of subjects: 12
Study 34521390 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5380
Study 34521390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5380
Study 35947305 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopists viewing slides with information on polyp size and location
Number of subjects: 7
Study 35947305 — intervention group
Group type: COMPARATOR
Intervention: Endoscopists viewing slides without information on polyp size and location
Number of subjects: 7
Study 35947305 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopists with ≥ 10 years of colonoscopy experience
Number of subjects: 7
Study 35947305 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopists evaluating inter-observer agreement
Number of subjects: 7
Study 35641218 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (n = 50)
Number of subjects: 361
Study 35641218 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice (IC) of chemotherapy (n = 26)
Number of subjects: 361
Study 32037284 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional Counseling (NC)
Number of subjects: 107
Study 32037284 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 107
Study 34537494 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT/CT aided botulinum toxin injection
Number of subjects: 108
Study 33198663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage for short cervix in women at high risk of preterm birth following a fully dilated caesarean section.
Number of subjects: 0
Study 33198663 — intervention group
Group type: COMPARATOR
Intervention: Current predictive models of preterm birth based on transvaginal ultrasound and quantitative fetal fibronectin.
Number of subjects: 0
Study 33198663 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational study evaluating subsequent pregnancy risk of preterm birth.
Number of subjects: 0
Study 33198663 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and transvaginal ultrasound imaging of cervical features.
Number of subjects: 0
Study 35259978 — intervention group
Group type: COMPARATOR
Intervention: Topiramate monotherapy 100 mg/day (group A)
Number of subjects: 125
Study 35259978 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate plus greater occipital nerve block with 40 mg lidocaine (2%) and 80mg (2 ml) methylprednisolone (group B)
Number of subjects: 125
Study 35259978 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate plus greater occipital nerve block with 40 mg lidocaine (2%) injections monthly for 3 months (group C)
Number of subjects: 125
Study 32413595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 439
Study 32413595 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (COMB)
Number of subjects: 439
Study 32413595 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 439